Analysis of Roch Holding AG - wave analysisExpecting fall in share price until 2026 = good moment to buy
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
13.8342 EUR
12.37 B EUR
63.18 B EUR
29.02 M
About ROCHE I
Sector
CEO
Thomas Schinecker
Headquarters
Basel
Website
Founded
1896
ISIN
CH0012032113
FIGI
BBG000BNH043
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Roche vs. Novo Nordisk: Who will suffer the Weight Loss?Roche (ticker: ROG.SW) is losing ground on the stock due to the side effects of its new weight loss pill, CT-996, which is still in the testing phase. After a rally that boosted its shares 40% between May and September, the Swiss drugmaker has seen an 11% drop in its shares in September alone, inclu
Roche Analysis 6/26DISCLOSURE: as of 6/26 I have no open position in SIX:RO
Roche is a Swiss based pharmaceutical conglomerate with a diverse range of operations and brands. The company has a long history of profitability and high returns on investment.
Management Effectiveness: Roche has been around since 1896
Roche: Ready for 120% Growth?We're trying something with Roche here, where we think that we are currently in Wave (5), having recently completed Wave (4). This assessment is better visualized on the daily chart. Hence, we should maintain the 61.8% level for this Wave 4. Anything below would statistically be too low, while above
Hold it like a rock - Roche, what an opportunity.Hi, 1PERCENT here.
Roche Holding, a Swiss multinational biopharma company. It is like the Apple of biopharma.
There were only 3 pull backs greater than 30% in the history of the stock.
2002 ~ 2003: -45.33%
2006 ~ 2011: -52.40%
2014 ~ 2018: -30.24%
2022 ~ present: -44.89%
It is at the support z
ROG corrective rally to come?ROG has experienced a 5 wave decline visible on the weekly timeframe. We can now expect at least a 3 wave corrective rally that can potentially reach the golden pocket at $332
Roche HoldingsThis is one of those companies you can't afford not to look into. Roche is one of the world's largest biotech companies and a global leader in pharmaceuticals and diagnostics. This leading position translates to strong market share, revenue, and profitability. The company operates across various seg
Long Term Weekly Trend holds for nowTrend started in 2012 held during the week. If the price accumulates at the current level and we breakout to the upside, I will watch the marked zones of interest and see how the price reacts.
If we breakout to the down side, I will look for interesting price levels and keep an eye on the trend est
Roche Holding AG (ROG.SW) Stock Hello ladies and gentlemen,
according to my stock chart analysis, there is a high probability of a decline toward the $303.50 level in the next few days!
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where RHO is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on DUS exchange ROCHE HLDG AG INH. SF 1 stocks are traded under the ticker RHO.
We've gathered analysts' opinions on ROCHE HLDG AG INH. SF 1 future price: according to them, RHO price has a max estimate of 468.91 EUR and a min estimate of 245.11 EUR. Watch RHO chart and read a more detailed ROCHE HLDG AG INH. SF 1 stock forecast: see what analysts think of ROCHE HLDG AG INH. SF 1 and suggest that you do with its stocks.
Yes, you can track ROCHE HLDG AG INH. SF 1 financials in yearly and quarterly reports right on TradingView.
ROCHE HLDG AG INH. SF 1 is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
RHO earnings for the last half-year are 10.62 EUR per share, whereas the estimation was 9.73 EUR, resulting in a 9.24% surprise. The estimated earnings for the next half-year are 9.01 EUR per share. See more details about ROCHE HLDG AG INH. SF 1 earnings.
ROCHE HLDG AG INH. SF 1 revenue for the last half-year amounts to 31.94 B EUR, despite the estimated figure of 30.75 B EUR. In the next half-year revenue is expected to reach 32.87 B EUR.
RHO net income for the last half-year is 6.50 B EUR, while the previous report showed 4.69 B EUR of net income which accounts for 38.48% change. Track more ROCHE HLDG AG INH. SF 1 financial stats to get the full picture.
Yes, RHO dividends are paid annually. The last dividend per share was 9.97 EUR. As of today, Dividend Yield (TTM)% is 3.68%. Tracking ROCHE HLDG AG INH. SF 1 dividends might help you take more informed decisions.
ROCHE HLDG AG INH. SF 1 dividend yield was 3.67% in 2023, and payout ratio reached 66.71%. The year before the numbers were 2.65% and 61.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 103.61 K employees. See our rating of the largest employees — is ROCHE HLDG AG INH. SF 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROCHE HLDG AG INH. SF 1 EBITDA is 20.60 B EUR, and current EBITDA margin is 33.76%. See more stats in ROCHE HLDG AG INH. SF 1 financial statements.
Like other stocks, RHO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROCHE HLDG AG INH. SF 1 stock right from TradingView charts — choose your broker and connect to your account.